DETROIT, Nov. 3, 2016 /PRNewswire/ -- A pioneering way to access the heart for transcatheter valve replacement has a 98% success rate, according to a study published in the Journal of the American College of Cardiology.
Henry Ford was the first hospital in the United States performing the unique procedure called transcaval valve replacement, which accesses the heart by temporarily connecting major blood vessels in the patient's abdomen. Cardiologist Adam Greenbaum, M.D., director of the Cardiac Catheterization Lab at Henry Ford Hospital, led the team who performed the first procedure at Henry Ford on July 3, 2013. The study published this week online in the Journal of the American College of Cardiology, reported a 98% success rate for the procedure in 100 patients in a multi-center trial. Dr. Greenbaum presented the results to interventional cardiologists gathered at the 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C. "There were some doubters, so the reason we did this prospective trial was to prove that it could be done safely," Greenbaum said at the conference focused on catheter-based treatments. "The success of this approach offers a new route for heart valve patients who may be out of options." Robert Lederman, M.D., an interventional cardiologist at the National Heart, Lung, and Blood Institute, developed the transcaval technique in a research setting. He came to Henry Ford in July 2013 to observe the initial procedure and share his insights. Since then, the procedure has been performed when the patients were either too sick for traditional open heart surgery, or their anatomy - like small arteries -- prevented the use of more traditional routes to the heart using a catheter.